Showing results (91-100 of 182) with videos related to
Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapyAngela Niehaus, Gregory S Merrick, Wayne M Butler, et al.International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trialGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Wayne M Butler, et al.BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.Cancer|June 6, 2007
Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancerGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.Pageof 19